Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective

Background: Radiofrequency ablation (RFA) is a minimally invasive alternative in the treatment of bone tumors. Long-term follow-up has not been described in current literature. Detailed analysis of mid- and long-term follow-up after RFA treatment for a cohort of patients with low-grade cartilaginous...

Full description

Bibliographic Details
Main Authors: Hendricus Nijland, Jelle Overbosch, Joris J. W. Ploegmakers, Thomas C. Kwee, Paul C. Jutte
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/9/1817
_version_ 1797536812352143360
author Hendricus Nijland
Jelle Overbosch
Joris J. W. Ploegmakers
Thomas C. Kwee
Paul C. Jutte
author_facet Hendricus Nijland
Jelle Overbosch
Joris J. W. Ploegmakers
Thomas C. Kwee
Paul C. Jutte
author_sort Hendricus Nijland
collection DOAJ
description Background: Radiofrequency ablation (RFA) is a minimally invasive alternative in the treatment of bone tumors. Long-term follow-up has not been described in current literature. Detailed analysis of mid- and long-term follow-up after RFA treatment for a cohort of patients with low-grade cartilaginous tumors (atypical cartilaginous tumors and enchondroma) was performed. The results, complications, and development of halo dimensions over time are presented. Methods: Data of all patients with an RFA procedure for an ACT between 2007–2018 were included. Ablation area is visible on baseline MRI, 3 months post-procedure, and is called halo. Volume was measured on MR images and compared to different follow-up moments to determine the effect of time on halo volume. Follow-up was carried out 3 months and 1, 2, 5, and 7 years after the procedure. Occurrence of complications and recurrences were assessed. Results: Of the 137 patients included, 82 were analyzed. Mean follow-up time was 43.6 months. Ablation was complete in 73 cases (89.0%). One late complication occurred, while no recurrences were seen. Halo dimensions of height, width, and depth decreased with a similar rate, 21.5% on average in the first year. Subsequently, this decrease in halo size continues gradually during follow-up, indicating bone revitalization. Conclusion: RFA is a safe and effective treatment in low-grade cartilaginous tumors with an initial success rate of 89.0%. Extended follow-up shows no local recurrences and gradual substitution of the halo with normal bone.
first_indexed 2024-03-10T12:06:09Z
format Article
id doaj.art-dce133823c5b4f09b2d3dd60ee9c165a
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T12:06:09Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-dce133823c5b4f09b2d3dd60ee9c165a2023-11-21T16:35:28ZengMDPI AGJournal of Clinical Medicine2077-03832021-04-01109181710.3390/jcm10091817Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and EffectiveHendricus Nijland0Jelle Overbosch1Joris J. W. Ploegmakers2Thomas C. Kwee3Paul C. Jutte4Department of Orthopaedic Surgery, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Radiology, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Orthopaedic Surgery, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Radiology, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Orthopaedic Surgery, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsBackground: Radiofrequency ablation (RFA) is a minimally invasive alternative in the treatment of bone tumors. Long-term follow-up has not been described in current literature. Detailed analysis of mid- and long-term follow-up after RFA treatment for a cohort of patients with low-grade cartilaginous tumors (atypical cartilaginous tumors and enchondroma) was performed. The results, complications, and development of halo dimensions over time are presented. Methods: Data of all patients with an RFA procedure for an ACT between 2007–2018 were included. Ablation area is visible on baseline MRI, 3 months post-procedure, and is called halo. Volume was measured on MR images and compared to different follow-up moments to determine the effect of time on halo volume. Follow-up was carried out 3 months and 1, 2, 5, and 7 years after the procedure. Occurrence of complications and recurrences were assessed. Results: Of the 137 patients included, 82 were analyzed. Mean follow-up time was 43.6 months. Ablation was complete in 73 cases (89.0%). One late complication occurred, while no recurrences were seen. Halo dimensions of height, width, and depth decreased with a similar rate, 21.5% on average in the first year. Subsequently, this decrease in halo size continues gradually during follow-up, indicating bone revitalization. Conclusion: RFA is a safe and effective treatment in low-grade cartilaginous tumors with an initial success rate of 89.0%. Extended follow-up shows no local recurrences and gradual substitution of the halo with normal bone.https://www.mdpi.com/2077-0383/10/9/1817percutaneousablationlow-grade cartilaginous tumorhaloresultscomplications
spellingShingle Hendricus Nijland
Jelle Overbosch
Joris J. W. Ploegmakers
Thomas C. Kwee
Paul C. Jutte
Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective
Journal of Clinical Medicine
percutaneous
ablation
low-grade cartilaginous tumor
halo
results
complications
title Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective
title_full Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective
title_fullStr Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective
title_full_unstemmed Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective
title_short Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective
title_sort long term halo follow up confirms less invasive treatment of low grade cartilaginous tumors with radiofrequency ablation to be safe and effective
topic percutaneous
ablation
low-grade cartilaginous tumor
halo
results
complications
url https://www.mdpi.com/2077-0383/10/9/1817
work_keys_str_mv AT hendricusnijland longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective
AT jelleoverbosch longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective
AT jorisjwploegmakers longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective
AT thomasckwee longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective
AT paulcjutte longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective